The National Institute on Drug Abuse (NIDA) awarded Oregon Health & Science University (OHSU) a 5-year, $1,362,860 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to study the co-use of cannabis and prescription opioids among emerging adults aged 18-25 in medical settings.
The study will prospectively follow a cohort of emerging adults, both with and without a history of cannabis use, who are prescribed opioid medications for acute pain management. The research aims to identify individual risk and protective factors that contribute to the development of problematic opioid and cannabis co-use during this critical developmental transition. Data will be collected on pain experiences, use of pharmacologic and non-pharmacologic pain management strategies, substance use patterns, and related psychosocial factors. The study's findings are expected to inform the design of targeted interventions that can reduce substance use disorders and chronic pain in emerging adults.
Generated 1/28/25, 7:45 AM